JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mildh, L. H.
Right arrow Articles by Kirvelä, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mildh, L. H.
Right arrow Articles by Kirvelä, O. A.
Related Collections
Right arrow Pharmacology
Anesth Analg 2001;93:939-946
© 2001 International Anesthesia Research Society


ANESTHETIC PHARMACOLOGY

The Concentration-Effect Relationship of the Respiratory Depressant Effects of Alfentanil and Fentanyl

Leena H. Mildh, MD*, Harry Scheinin, MD PhD{dagger}, and Olli A. Kirvelä, MD PhD{ddagger}

*Department of Anesthesia and Intensive Care, Helsinki University Hospital, Helsinki, Finland; and {dagger}Department of Clinical Pharmacology and {ddagger}Department of Anesthesia, Turku University Hospital, Turku, Finland

Address correspondence and reprint requests to Leena Mildh, MD, Department of Anesthesia, Helsinki University Hospital, Hospital for Children and Adolescents, PO BOX 281, FIN-00029 HUS, Finland. Address e-mail to leena.mildh{at}hus.fi

The relative potencies of fentanyl and alfentanil for respiratory depression were determined in eight healthy male volunteers in a double-blinded, randomized study with a cross-over design. The drugs were delivered by computer-driven infusion with logarithmically ascending plasma concentrations until the respiratory rate reached 2/min and/or oxygen saturation decreased below 85% with subjects breathing room air. Ventilation was measured with respiratory inductive plethysmography, indirect calorimetry, and arterial blood gas analysis, and plasma drug concentrations were determined. Pharmacodynamic modeling was performed using a fractional Emax model for minute volume and respiratory rate and the concentrations producing 50% depression (i.e., apparent 50% effective concentration [EC50] values) were determined. Both drugs decreased ventilation in a similar manner, and drug infusions were terminated at mean ± SD measured plasma concentrations of 254 ± 88 ng/mL and 5.1 ± 1.7 ng/mL for alfentanil and fentanyl, respectively. Alfentanil decreased minute volume from baseline by 54% ± 19% and respiratory rate by 40% ± 11% with EC50 values of 234 ± 57 ng/mL and 195 ± 101 ng/mL. The respective decreases for fentanyl were 50% ± 11%, 41% ± 15%, and the estimated EC50 values were 6.1 ± 1.4 ng/mL and 3.5 ± 1.4 ng/mL, respectively. Using the apparent EC50 values, the calculated potency ratio for alfentanil:fentanyl was (mean and 95% confidence interval) 1:39 (1:31–1:46) for minute volume and 1:51 (1:34–1:68) for respiratory rate. This is analogous to the analgesic effect studied earlier. The findings support the notion of parallel analgesic and respiratory depressant effects of alfentanil and fentanyl. Therefore equianalgesic concentrations of both drugs will lead to equally pronounced respiratory depression.

IMPLICATIONS: This double-blinded, randomized study evaluated the potency ratio of alfentanil and fentanyl-induced respiratory depression. The findings support the notion of parallel analgesic and respiratory depressant effects of alfentanil and fentanyl. Therefore equianalgesic concentrations of both drugs will lead to equally pronounced respiratory depression.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Dahan, A. Yassen, H. Bijl, R. Romberg, E. Sarton, L. Teppema, E. Olofsen, and M. Danhof
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats
Br. J. Anaesth., June 1, 2005; 94(6): 825 - 834.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Lahtinen, H. Kokki, T. Hakala, and M. Hynynen
S(+)-Ketamine as an Analgesic Adjunct Reduces Opioid Consumption After Cardiac Surgery
Anesth. Analg., November 1, 2004; 99(5): 1295 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Dahan and L. J. Teppema
Influence of anaesthesia and analgesia on the control of breathing
Br. J. Anaesth., July 1, 2003; 91(1): 40 - 49.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Iwakiri, O. Nagata, T. Matsukawa, M. Ozaki, and D. I. Sessler
Effect-Site Concentration of Propofol for Recovery of Consciousness Is Virtually Independent of Fentanyl Effect-Site Concentration
Anesth. Analg., June 1, 2003; 96(6): 1651 - 1655.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.